Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The FDA greenlights lenacapavir, a semi-annual injectable that prevents infection in over 96% of cases. From a daily pill for ...

The FDA approval marks the first approval of a type of pre-exposure prophylaxis that would only require 2 treatments per year ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

The Trump administration has ended a program seeking a vaccine for HIV, the first in a series of decisions that is leaving ...

Amy Grant joined artists Matt Maher, Brandon Health, Charlie Peacock and Steve Taylor at a performance at Otter Creek Church ...

FRIDAY, June 20, 2025 (HealthDay News) — A new shot to prevent HIV infection has just been approved — and it only needs to be ...

A research team led by Professor Chu Hin (first right) and Professor Chen Zhiwei (first left) has discovered that inhibiting ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.

The University of Zimbabwe Clinical Trials Research Centre (UZ-CTRC) is intensifying its efforts to find a cure for HIV, as ...